Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression

Amber R. Smith; Rebecca T. Marquez; Wei-chung Tsao; Surajit Pathak; Alexandria Roy; Jie Ping; Bailey Wilkerson; Lan Lan; Wenjian Meng; Kristi L. Neufeld; Xiao-Feng Sun; Liang Xu

doi:10.18632/oncotarget.3726

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression

Amber R. Smith, Rebecca T. Marquez, Wei-chung Tsao, Surajit Pathak, Alexandria Roy, Jie Ping, Bailey Wilkerson, Lan Lan, Wenjian Meng, Kristi L. Neufeld, Xiao-Feng Sun and Liang Xu _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:12558-12573. https://doi.org/10.18632/oncotarget.3726

Metrics: PDF 2296 views | HTML 3112 views | ?

Abstract

Amber R. Smith1, Rebecca T. Marquez1, Wei-Chung Tsao1, Surajit Pathak3, Alexandria Roy1, Jie Ping3, Bailey Wilkerson1, Lan Lan1, Wenjian Meng3, Kristi L. Neufeld1,4, Xiao-Feng Sun3 and Liang Xu1,2

1 Department of Molecular Biosciences, University of Kansas, Lawrence, KS, USA

2 Department of Radiation Oncology, The Kansas University Medical Center, Kansas City, KS, USA

3 Department of Oncology, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

4 Department of Cancer Biology, The Kansas University Medical Center, Kansas City, KS, USA

Correspondence to:

Liang Xu, email:

Keywords: tumor-initiating cells, microRNAs, RNA-binding proteins, colon cancer, rectal cancer

Received: September 25, 2014 Accepted: March 04, 2015 Published: May 20, 2015

Abstract

Stem cell marker, Musashi-1 (MSI1) is over-expressed in many cancer types; however the molecular mechanisms involved in MSI1 over-expression are not well understood. We investigated the microRNA (miRNA) regulation of MSI1 and the implications this regulation plays in colorectal cancer. MicroRNA miR-137 was identified as a MSI1-targeting microRNA by immunoblotting and luciferase reporter assays. MSI1 protein was found to be highly expressed in 79% of primary rectal tumors (n=146), while miR-137 expression was decreased in 84% of the rectal tumor tissues (n=68) compared to paired normal mucosal samples. In addition to reduced MSI1 protein, exogenous expression of miR-137 inhibited cell growth, colony formation, and tumorsphere growth of colon cancer cells. Finally, in vivo studies demonstrated that induction of miR-137 can decrease growth of human colon cancer xenografts. Our results demonstrate that miR-137 acts as a tumor-suppressive miRNA in colorectal cancers and negatively regulates oncogenic MSI1.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3726

Publication Alerts

Research Papers:

Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression

Abstract